Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...

EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...

Regulatory ApprovalFormycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / 06:30 CET/CESTThe issuer is solely ...

However, in the past six months Elbit's share price has gained upward momentum. Since the end of June the company's share ...

2024 was an active year in the class action arena. In this post, our Litigation group in Toronto discusses noteworthy ...

All you need is the right gear, like warm layers and YakTrax, to enjoy this scenic winter hike in Minnesota along Lake ...

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...

The retail sector suffered for months before starting to show signs of recovery in the second half of last year as the ...

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Kraft Heinz Canada is deeply disappointed that Prime Minister Trudeau has made misleading statements that HEINZ Ketchup is ...